Loading clinical trials...
Loading clinical trials...
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia: A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy (Phase II Study)
Conditions
Interventions
Sildenafil
Ora-Blend
Locations
2
Canada
Montreal Children's Hospital
Montreal, Quebec, Canada
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
Start Date
July 1, 2024
Primary Completion Date
October 1, 2027
Completion Date
June 1, 2028
Last Updated
January 14, 2025
NCT05514340
NCT02544100
NCT03706417
NCT06985303
NCT06985290
NCT05966714
Lead Sponsor
Pia Wintermark
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions